Cargando…

Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy

Vaccination against COVID-19 is one of the highly effective preventative strategies to reduce morbidity and mortality associated with COVID-19 infection. The rapid approval of COVID-19 vaccination due to the raging pandemic, media coverage, anti-vaccination groups, and concerns about adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Saral, Kainth, Tejasvi, Yadav, Garima, Kochhar, Hansini, Srinivas, Sushma, Kamil, Saher, Du, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222544/
https://www.ncbi.nlm.nih.gov/pubmed/37243026
http://dx.doi.org/10.3390/vaccines11050922
_version_ 1785049724469903360
author Desai, Saral
Kainth, Tejasvi
Yadav, Garima
Kochhar, Hansini
Srinivas, Sushma
Kamil, Saher
Du, Wei
author_facet Desai, Saral
Kainth, Tejasvi
Yadav, Garima
Kochhar, Hansini
Srinivas, Sushma
Kamil, Saher
Du, Wei
author_sort Desai, Saral
collection PubMed
description Vaccination against COVID-19 is one of the highly effective preventative strategies to reduce morbidity and mortality associated with COVID-19 infection. The rapid approval of COVID-19 vaccination due to the raging pandemic, media coverage, anti-vaccination groups, and concerns about adverse effects associated with vaccination has given rise to COVID-19 vaccine hesitancy. Current evidence suggests that psychosomatic and nocebo-related adverse effects account for a significant proportion of common adverse effects following COVID-19 vaccination. The most common adverse effects are headache, fatigue, and myalgia, which are highly prone to nocebo effects. In our review article, we discuss the role of psychosomatic and nocebo effects in COVID-19 vaccination-related hesitancy, predictors of such effects, and strategies to reduce vaccine hesitancy. General education regarding psychosomatic and nocebo effects and specialized education for at-risk populations may reduce psychosomatic and nocebo-related adverse effects following COVID-19 vaccination, ultimately reducing hesitancy.
format Online
Article
Text
id pubmed-10222544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102225442023-05-28 Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy Desai, Saral Kainth, Tejasvi Yadav, Garima Kochhar, Hansini Srinivas, Sushma Kamil, Saher Du, Wei Vaccines (Basel) Opinion Vaccination against COVID-19 is one of the highly effective preventative strategies to reduce morbidity and mortality associated with COVID-19 infection. The rapid approval of COVID-19 vaccination due to the raging pandemic, media coverage, anti-vaccination groups, and concerns about adverse effects associated with vaccination has given rise to COVID-19 vaccine hesitancy. Current evidence suggests that psychosomatic and nocebo-related adverse effects account for a significant proportion of common adverse effects following COVID-19 vaccination. The most common adverse effects are headache, fatigue, and myalgia, which are highly prone to nocebo effects. In our review article, we discuss the role of psychosomatic and nocebo effects in COVID-19 vaccination-related hesitancy, predictors of such effects, and strategies to reduce vaccine hesitancy. General education regarding psychosomatic and nocebo effects and specialized education for at-risk populations may reduce psychosomatic and nocebo-related adverse effects following COVID-19 vaccination, ultimately reducing hesitancy. MDPI 2023-04-30 /pmc/articles/PMC10222544/ /pubmed/37243026 http://dx.doi.org/10.3390/vaccines11050922 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Desai, Saral
Kainth, Tejasvi
Yadav, Garima
Kochhar, Hansini
Srinivas, Sushma
Kamil, Saher
Du, Wei
Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
title Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
title_full Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
title_fullStr Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
title_full_unstemmed Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
title_short Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
title_sort role of psychosomatic symptoms in covid-19 vaccine hesitancy
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222544/
https://www.ncbi.nlm.nih.gov/pubmed/37243026
http://dx.doi.org/10.3390/vaccines11050922
work_keys_str_mv AT desaisaral roleofpsychosomaticsymptomsincovid19vaccinehesitancy
AT kainthtejasvi roleofpsychosomaticsymptomsincovid19vaccinehesitancy
AT yadavgarima roleofpsychosomaticsymptomsincovid19vaccinehesitancy
AT kochharhansini roleofpsychosomaticsymptomsincovid19vaccinehesitancy
AT srinivassushma roleofpsychosomaticsymptomsincovid19vaccinehesitancy
AT kamilsaher roleofpsychosomaticsymptomsincovid19vaccinehesitancy
AT duwei roleofpsychosomaticsymptomsincovid19vaccinehesitancy